Xconomy National

Archives

by in

Entry	Author	Date	Location
Ariad Brings Third Cancer Drug Into Human Trials	Arlene Weintraub	09/22/11	Boston
Aura Adds $4.5M, Syndax To Present Breast Cancer Results at ASCO, PKE Buys Caliper, & More Boston-Area Life Sciences News	Erin Kutz	09/09/11	Boston
Lead Syndax Drug Shows Survival Benefits in Breast Cancer Trial	Arlene Weintraub	09/06/11	Boston
Aria Shows Drug Data at ASCO, Pfizer Supports Selecta, WPI Adds Big Pharma Partners, & More Boston-Area Life Sciences News	Erin Kutz	06/10/11	Boston
Stemline Makes Headway Against Cancer Stem Cells And Proves Value of Virtual Model	Arlene Weintraub	06/08/11	New York
Ariad and Merck Say Sarcoma Drug Improves Survival	Arlene Weintraub	06/06/11	Boston
Ariad and Infinity to Reveal Data at ASCO, Excelimmune Gets $10.5M, Hologic Buys TCT, & More Boston-Area Life Sciences News	Erin Kutz	06/03/11	Boston
New York Area Companies Head to ASCO With High Hopes For Future Cancer Blockbusters	Arlene Weintraub	06/01/11	New York
Cyclacel Looks to ASCO as Showcase for Potent Cancer-Fighting Cocktail	Arlene Weintraub	05/31/11	New York
Vertex Gets FDA OK, Alnylam Plans For ASCO, Biogen Drug Advances in Europe, & More Boston-Area Life Sciences News	Erin Kutz	05/27/11	Boston
Alnylam Looks to ASCO as First “Bell-Ringing” for RNAi Resurgence	Arlene Weintraub	05/26/11	Boston
Glaxo’s SR One Injects Pharma Bucks into $22M Round for Constellation Pharma	Ryan McBride	06/02/10	Boston
Prepared Response Raises $6.3M, Cell Therapeutics Loses Debt, RealNetworks Gets Into Netbooks, & More Seattle-Area Deals News	Gregory T. Huang	06/09/09	Seattle
ASCO Sneak Peek: ImmunoGen, Biogen Idec, Infinity Show Glimpses of Cancer Drug Data	Luke Timmerman	05/15/09	Boston
BioVex Viral Treatment Shrinks Melanoma Tumors in Trial	Luke Timmerman	06/01/08	Boston
Page 1 of 1